1 August 2025 true Taxfiler 2024.6 16595594business:PrivateLimitedCompanyLtd2025-08-012026-07-31 165955942025-07-31 16595594business:EntityHasNeverTraded2025-08-012026-07-31 165955942025-08-012026-07-31 16595594business:AuditExemptWithAccountantsReport2025-08-012026-07-31 16595594business:FilletedAccounts2025-08-012026-07-31 165955942026-07-31 16595594business:Director12025-08-012026-07-31 16595594business:Director22025-08-012026-07-31 16595594business:RegisteredOffice2025-08-012026-07-31 16595594core:ShareCapitalcore:PreviouslyStatedAmount2026-07-31 16595594core:PreviouslyStatedAmount2026-07-31 16595594business:SmallEntities2025-08-012026-07-31 16595594countries:EnglandWales2025-08-012026-07-31 16595594business:OrdinaryShareClass12025-08-012026-07-31 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 16595594 (England and Wales)
Neurogastroenterology and Digestive Disease Centre Ltd Filleted Accounts for the year ended 31 July 2026
Neurogastroenterology and Digestive Disease Centre Ltd Filleted Accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
Neurogastroenterology and Digestive Disease Centre Ltd Company Information for the year ended 31 July 2026
Directors
Dr Affifa Farrukh Professor John Francis Mayberry
Company Number
16595594 (England and Wales)
Registered Office
81 Downing Drive Leicester Leicestershire LE5 6LL England
Accountants
YP Finance Hawthorne House 17A Hawthorne Drive Leicester Leicestershire LE5 6DL
- 3 -
Neurogastroenterology and Digestive Disease Centre Ltd Statement of financial position as at 31 July 2026
2026 
Notes
£ 
Current assets
Cash at bank and in hand
100 
Net current assets
100 
Net assets
100 
Capital and reserves
Called up share capital
4
100 
Shareholders' funds
100 
For the year ending 31 July 2026 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 6 October 2026 and were signed on its behalf by
Dr Affifa Farrukh Director Company Registration No. 16595594
- 4 -
Neurogastroenterology and Digestive Disease Centre Ltd Notes to the Accounts for the year ended 31 July 2026
1
Statutory information
Neurogastroenterology and Digestive Disease Centre Ltd is a private company, limited by shares, registered in England and Wales, registration number 16595594. The registered office is 81 Downing Drive, Leicester, Leicestershire, LE5 6LL, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
4
Share capital
2026 
£ 
Allotted, called up and fully paid:
100 Ordinary shares of £1 each
100 
Shares issued during the period:
100 Ordinary shares of £1 each
100 
5
Average number of employees
During the year the average number of employees was 0.
- 5 -